U.S. Markets open in 7 hrs 55 mins
  • S&P Futures

    3,449.50
    +0.25 (+0.01%)
     
  • Dow Futures

    28,273.00
    +5.00 (+0.02%)
     
  • Nasdaq Futures

    11,656.75
    +7.00 (+0.06%)
     
  • Russell 2000 Futures

    1,632.30
    +1.70 (+0.10%)
     
  • Crude Oil

    40.53
    -0.11 (-0.27%)
     
  • Gold

    1,907.60
    +3.00 (+0.16%)
     
  • Silver

    24.73
    +0.02 (+0.08%)
     
  • EUR/USD

    1.1806
    -0.0020 (-0.1653%)
     
  • 10-Yr Bond

    0.8480
    0.0000 (0.00%)
     
  • Vix

    28.11
    -0.54 (-1.88%)
     
  • GBP/USD

    1.3055
    -0.0025 (-0.1893%)
     
  • USD/JPY

    104.7150
    -0.1250 (-0.1192%)
     
  • BTC-USD

    12,953.46
    +48.48 (+0.38%)
     
  • CMC Crypto 200

    261.38
    +5.28 (+2.06%)
     
  • FTSE 100

    5,785.65
    +9.15 (+0.16%)
     
  • Nikkei 225

    23,571.31
    +97.04 (+0.41%)
     

A Trio of Stocks Growing Earnings Fast

GuruFocus.com
·4 mins read

Growing earnings can often push share prices up. The S&P 500 Index, which is a benchmark for the U.S. market, has grown its annual earnings per share (not adjusted for inflation) by about 6.5% every year over the past five years. On the tailwind of this, the share price of the index increased by nearly 49% over the past five years, closing at a price of $3,003.37 on March 3, 2020.


Past performance is not a guarantee of future results, but it does indicate that a company has a better foundation on which to grow.

As a result of strong past results, Wall Street sell-side analysts have released bullish recommendation ratings for Novo Nordisk A/S (NYSE:NVO), Booz Allen Hamilton Holding Corp (NYSE:BAH) and Otter Tail Corp (NASDAQ:OTTR).

Novo Nordisk

The Danish biotechnology company has grown its trailing 12-month earnings per share without non-recurring items by nearly 8% every year over the past five full fiscal years. As a result, the share price ($61.50 as of March 3) has risen by 35% over the past five years.

The stock has a market capitalization of $144.40 billion, a price-earnings ratio of 25.6 versus the industry median of 33.9 and a price-sales ratio of 8.17 versus the industry median of 10.39.

Wall Street recommends an overweight rating for shares of Novo Nordisk with an average price target of $64.49 per share.

GuruFocus assigned a high rating of 8 out of 10 for the company's financial strength and the highest rating of 10 out of 10 for its profitability.

Booz Allen Hamilton Holding Corp

Booz Allen Hamilton is a McLean, Northern Virginia-based provider of management and technology consulting, engineering and cyber solutions to U.S. and international entities.

The chart below shows that it has grown its trailing 12-month earnings per share without non-recurring items by nearly 12% every year over the past five full fiscal years, producing a 155% increase in the share price ($74.62 as of March 3).

The stock has a market capitalization of $10.46 billion, a price-earnings ratio of 24.39 versus the industry median of 15.65 and a price-sales ratio of 1.45 versus the industry median of 0.93.

Wall Street recommends an overweight rating for shares of Booz Allen Hamilton Holding Corp and has set a price target of $85.15 per share.

GuruFocus assigned the company a positive financial strength rating of 6 out of 10 and a high profitability rating of 8 out of 10.

Otter Tail Corp

The chart below shows that the Fergus Falls, Minnesota-based regional electric company has grown its trailing 12-month earnings per share without non-recurring items by 7.8% every year over the past five full fiscal years. On the tailwind of this, the share price ($49.45 as of March 3) increased by nearly 56%.

The stock has a market capitalization of $2.02 billion, a price-earnings ratio of 23.08 versus the industry median of 16.35 and a price-sales ratio of 2.19 versus the industry median of 1.38.

Wall Street recommends an overweight rating for shares of Otter Tail Corp and has established an average price target of $57 per share.

GuruFocus assigned a moderate rating of 4 out of 10 for the company's financial strength and a positive rating of 6 out of 10 for its profitability.

Disclosure: I have no positions in any securities mentioned in this article.

Read more here:



Not a Premium Member of GuruFocus? Sign up for a free 7-day trial here.

This article first appeared on GuruFocus.